The Immediate Effect of Electrical Stimulation Transcranial Direct Current (tDCS) Associated With the Use of FES, in Muscle Activity of the Tibialis Anterior Muscle, Balance and Plantar Pressure Distribution of Individuals With Hemiparesis Due to Stroke
STROKE
About this trial
This is an interventional treatment trial for STROKE focused on measuring Transcranial direct current stimulation, functional electrical stimulation, hemiparesis, electromyography, balance
Eligibility Criteria
Inclusion criteria:
- 30 individuals with hemiparesis stemming from a stroke;
- Either gender;
- Able to maintain a standing position without an assistance device for at least 60 seconds;
- Signed statement of written consent.
Exclusion criteria:
- Adverse health condition (beyond hemiparesis) that affects balance;
- Use of medication that can affect balance;
- Positive cutoff point for cognitive deficit (Mini Mental State Examination);
- Illiteracy;
- Wernicke's aphasia;
- Reduced ankle mobility due to history of ankle fracture and use of pins in ankle;
- TA muscle strength less than grade 1;
- Contraindication for tDCS (history of recurrent seizures, recurrent epilepsy and brain tumor in stimulation site);
- Skin infection at tDCS and/or FES site;
- Anesthesia or hyperesthesia at FES site.
Sites / Locations
- University Nove de Julho
Arms of the Study
Arm 1
Experimental
1- tDCS 2--FES
Transcranial stimulation ( tDCS ) will be administered using Tct Research 1 CH tdcs Simulator model 101. tDCS will be performed for 20 minutes and intensity 2mA associated active contraction of the TA muscle. Placebo tDCS will follow the same procedures as active tDCS with active, but the tDCS device will only be switched on for 20 seconds. Functional electrical stimulation (FES) will be administered using QUARK® FES VIF 995 DUAL device. The duration of active FES will be 20 minutes, associated with active contraction of the TA muscle. The pulse width will be 250 µs, modulated at a frequency of 50 Hz, with one to two stimulation cycles (6 seconds on and 12 seconds off) and the intensity will be increased until reaching the motor threshold. Placebo FES will follow the same procedures as active FES , but the FES device will only be switched on for 20 seconds, following which the intensity will be gradually reduced to 0 mA.